サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1433294

自己創傷パッチの世界市場：2023-2030年

Global Autologous Wound Patches Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 210 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
自己創傷パッチの世界市場：2023-2030年
出版日: 2023年12月01日
発行: Orion Market Research
ページ情報: 英文 210 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の自己創傷パッチ市場は、予測期間（2023-2030年）にCAGR 9.2％で成長すると予測されています。自己創傷パッチは、創傷治癒を促進し、合併症のリスクを低減することができるため、患者に新たな治療オプションを提供します。全身の皮膚損傷は、何百万人もの患者の日常生活を妨げ続け、入院の長期化、感染症、死亡の原因となっています。創傷治療器具の進歩により臨床現場は改善されたが、主にマクロスケールの創傷治癒と、その根底にあるミクロスケールの病態生理の治療に焦点が当てられてきました。様々な創傷治癒器具を用いた最適な治療戦略についてはコンセンサスが得られていないため、新たな治療法の開発が望まれています。

セグメント別の展望

自己創傷パッチの世界市場では慢性創傷サブセグメントが大きなシェアを占めると予測される

用途別では、慢性創傷サブセグメントが世界の自己創傷パッチ市場でかなりのシェアを占めると予想されています。このセグメントの成長は、慢性創傷、高度な包帯が調節不全の炎症相をターゲットにし、皮膚組織を置換し、感染から保護するなどのいくつかの要因に起因しています。糖尿病性創傷では、最近、急性炎症を誘発することで治癒プロセスを飛躍的に促進させることに注目が集まっています。肥満細胞安定剤の予防的投与と神経ペプチドサブスタンスPの放出は、ともに糖尿病マウスにおいて創傷後の強い炎症を誘発し、創傷の再上皮化を改善し、創傷治癒を促進しました。世界保健機関（WHO）によると、世界中で約4億2,200万人が糖尿病を患っており、その大半は低所得国と中所得国に住んでいます。毎年150万人が糖尿病が直接の原因で死亡しており、糖尿病の症例数と有病率はどちらも過去数十年にわたって着実に増加しています。

地域別展望

世界の自己創傷パッチ市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、南米）を含む地域別にさらに細分化されています。なかでもアジア太平洋地域は、交通事故や外傷事故の増加に伴い、複雑な創傷を持つ患者数が増加していることから、世界市場で大きなシェアを占めると予想されています。自己創傷パッチは、組織の再生を促進し、損傷を容易に修復することができるため、こうしたタイプの創傷の治療に特に適しています。

欧州地域は世界の自己創傷パッチ市場において著しいCAGRで成長すると予想される

すべての地域の中で、欧州地域は予測期間中にかなりのCAGRで成長すると予測されています。同地域の成長は、同地域における医療の進歩と技術革新に起因しています。治癒時間の短縮、痛みや不快感の軽減、使いやすさなどの特性が改善された、新しく革新的な自己創傷パッチの開発に注目が集まっています。例えば、2023年7月、患者自身の全血から作製される個別化された自己血創傷治療ソリューションであるレッドドレス社は、同社のActiGraft PRO製品が米国内で市販され、NCD 270.3およびG-0465 &G-0460コードを通じてメディケアおよびメディケア・アドバンテージから全国的に払い戻しを受けることができるようになったと発表しました。一旦適用されると、血餅は保護カバーとして機能し、身体の自然な創傷治癒反応をサポートします。糖尿病性足潰瘍、褥瘡、静脈性潰瘍、外傷性創傷、術後創傷など、治療が困難な様々な慢性創傷に使用できます。

目次

第1章 レポート概要

  • 業界の現状分析と成長の可能性の展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • PRP Concepts
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Reapplix A/S
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • RedDress
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 自己創傷パッチの世界市場：タイプ別
    • 多血小板血漿
    • 血小板リッチフィブリン
  • 自己創傷パッチの世界市場：用途別
    • 急性創傷
    • 慢性創傷
  • 自己創傷パッチの世界市場：エンドユーザー別
    • 病院
    • 診療所
    • 外来手術センター

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • 3M Healthcare
  • ACell Inc.
  • Advanced BioHealing
  • AlloSource
  • Avita Medical
  • Coloplast
  • ConvaTec
  • Integra LifeSciences Corp
  • MiMedx Group, Inc.
  • Molnlycke Health Care AB
  • Nuo Therapeutics
  • NuVasive
  • Organogenesis Holdings Inc.
  • Osiris Therapeutics, Inc.
  • Smith & Nephew plc
  • TissueTech, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL PLATELET RICH PLASMA IN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL PLATELET RICH FIBRIN IN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL AUTOLOGOUS WOUND PATCHES IN ACUTE WOUND MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AUTOLOGOUS WOUND PATCHES IN CHRONIC WOUND MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 8. GLOBAL AUTOLOGOUS WOUND PATCHES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL AUTOLOGOUS WOUND PATCHES FOR CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL AUTOLOGOUS WOUND PATCHES FOR AMBULATORY SURGICAL CENTER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 16. EUROPEAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 18. EUROPEAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 19. EUROPEAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 20. ASIA- PACIFIC AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. ASIA- PACIFIC AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 22. ASIA- PACIFIC AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL PLATELET RICH PLASMA IN AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL PLATELET RICH FIBRIN IN AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL ACUTE WOUND AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL CHRONIC WOUND AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 8. GLOBAL AUTOLOGOUS WOUND PATCHES FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AUTOLOGOUS WOUND PATCHES FOR CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL AUTOLOGOUS WOUND PATCHES FOR AMBULATORY SURGICAL CENTER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. US AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. CANADA AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. UK AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. FRANCE AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. GERMANY AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. ITALY AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. SPAIN AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. REST OF EUROPE AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. INDIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. CHINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. JAPAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SOUTH KOREA AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027930

Global Autologous Wound Patches Market Size, Share & Trends Analysis Report by Type (Platelet Rich Plasma and Platelet Rich Fibrin), by Application (Acute wound and chronic wound), and by End-User (Hospitals, Clinics, and Ambulatory Surgical Center), Forecast Period (2023-2030)

The global autologous wound patches market is anticipated to grow at a CAGR of 9.2% during the forecast period (2023-2030). Autologous wound patches offer new treatment option for patients, as they can help to accelerate wound healing and reduce the risk of complications. Skin injuries across the body continue to disrupt everyday life for millions of patients and result in prolonged hospital stays, infection, and death. Advances in wound healing devices have improved clinical practice but have mainly focused on treating macroscale healing versus underlying microscale pathophysiology. Consensus is lacking on optimal treatment strategies using a spectrum of wound healing products, which has motivated the design of new therapies.

Segmental Outlook

The global autologous wound patches market is segmented on the type, application, and end-user. Based on the type, the market is sub-segmented into platelet rich plasma and platelet rich fibrin. Based on application, the market is sub-segmented into acute wound and chronic wound. Based on the end-user, the market is sub-segmented into a hospitals, clinics, and ambulatory surgical center. Among the type, the Platelet rich fibrin sub-segment is anticipated to hold a considerable share of the market, owing to factor which includes, it spun at a lower speed, which allows some of the white blood cells & stem cells to remain intact with the platelet layer, as a result, more healing factors are present in platelet rich fibrin patches, which supports faster healing of chronic wounds.

The chronic wound Sub-Segment is Anticipated to Hold a Considerable Share of the Global Autologous wound patches Market

Among the application, the chronic wound sub-segment is expected to hold a considerable share of the global Autologous wound patches market. This segmental growth is attributed to several factor such as, chronic wounds, advanced bandages target the dysregulated inflammatory phase, replace skin tissue, and protect against infection. In diabetic wounds, recent attention focused on jump-starting the healing process by inducing acute inflammation. The preventive delivery of a mast cell stabilizer and the release of the neuropeptide substance P both induced strong inflammation after wounding, improved wound re-epithelialization, and accelerated wound healing in diabetic mice. According to World health organization, about 422 million people worldwide have diabetes, the majority living in low-and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades.

Regional Outlook

The global autologous wound patches market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to Increasing number of road and traumatic accidents in the region, leading to a rise in the number of patients with complex wounds. Autologous wound patches are particularly suitable for treating these types of wounds, as they can help to promote tissue regeneration and repair the damage easily.

The European Region is Expected to Grow at a Significant CAGR in the Global Autologous wound patches Market

Among all regions, the European regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to medical advancements and innovation in the region. There is a growing focus on developing new and innovative autologous wound patches with improved properties such as faster healing times, reduced pain and discomfort, and ease of use. For instance, In July 2023, RedDress, a personalized and autologous wound care solution created from patients own whole blood, announced that its ActiGraft PRO product is now commercially available throughout the US and is eligible for reimbursement nationally from Medicare and Medicare Advantage via NCD 270.3 and G-0465 & G-0460 codes. it enables health care providers to produce, 'in real time' in vitro blood clots from a patient's own blood. Once applied, the blood clot serves as a protective covering and supports the body's natural wound healing response. it can be used for a wide variety of hard-to-treat chronic wounds, including diabetic foot ulcers, pressure injuries, venous ulcers, traumatic wounds and post-surgical wounds.

Market Players Outlook

The major companies serving the autologous wound patches market include Reapplix, PRP Concepts, RedDress, Nuo Therapeutics, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In August 2023, RedDress, developers of the ActiGraft PRO system, a personalized and autologous wound care solution created from patients' own whole blood, announced that its ActiGraft PRO product is now available through Vizient, the nation's largest provider-driven healthcare performance improvement company. Additionally, it announced also established a strategic partnership with OneMed, part of the Asker Healthcare Group, to commercialize and distribute the ActiGraft system throughout Finland.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global autologous wound patches market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. PRP Concepts
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Reapplix A/S
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. RedDress
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Autologous wound patches Market by Type
    • 4.1.1. Platelet Rich Plasma
    • 4.1.2. Platelet Rich Fibrin
  • 4.2. Global Autologous wound patches Market by Application
    • 4.2.1. Acute wound
    • 4.2.2. Chronic wound
  • 4.3. Global Autologous wound patches Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Clinics
    • 4.3.3. Ambulatory Surgical Center

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 3M Healthcare
  • 6.2. ACell Inc.
  • 6.3. Advanced BioHealing
  • 6.4. AlloSource
  • 6.5. Avita Medical
  • 6.6. Coloplast
  • 6.7. ConvaTec
  • 6.8. Integra LifeSciences Corp
  • 6.9. MiMedx Group, Inc.
  • 6.10. Molnlycke Health Care AB
  • 6.11. Nuo Therapeutics
  • 6.12. NuVasive
  • 6.13. Organogenesis Holdings Inc.
  • 6.14. Osiris Therapeutics, Inc.
  • 6.15. Smith & Nephew plc
  • 6.16. TissueTech, Inc.